Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.

MLA

Ooi, Choon Jin, et al. “Best Practices on Immunomodulators and Biologic Agents for Ulcerative Colitis and Crohn’s Disease in Asia.” Journal of Gastroenterology & Hepatology, vol. 34, no. 8, Aug. 2019, pp. 1296–315. EBSCOhost, https://doi.org/10.1111/jgh.14648.

APA

Ooi, C. J., Hilmi, I., Banerjee, R., Chuah, S. W., Ng, S. C., Wei, S. C., Makharia, G. K., Pisespongsa, P., Chen, M. H., Ran, Z. H., Ye, B. D., Park, D. I., Ling, K. L., Ong, D., Ahuja, V., Goh, K. L., Sollano, J., Lim, W. C., Leung, W. K., & Ali, R. A. R. (2019). Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia. Journal of Gastroenterology & Hepatology, 34(8), 1296–1315. https://doi.org/10.1111/jgh.14648

Chicago

Ooi, Choon Jin, Ida Hilmi, Rupa Banerjee, Sai Wei Chuah, Siew Chien Ng, Shu Chen Wei, Govind K Makharia, et al. 2019. “Best Practices on Immunomodulators and Biologic Agents for Ulcerative Colitis and Crohn’s Disease in Asia.” Journal of Gastroenterology & Hepatology 34 (8): 1296–1315. doi:10.1111/jgh.14648.